Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension | Zendy

Clyde Schultz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension

Author(s) -

Clyde Schultz

Publication year - 2011

Publication title -

ophthalmology and eye diseases

Language(s) - English

Resource type - Journals

ISSN - 1179-1721

DOI - 10.4137/oed.s4253

Subject(s) - glaucoma , medicine , intraocular pressure , ophthalmology , ocular hypertension , open angle glaucoma , reduction (mathematics) , optometry , geometry , mathematics

Tafluprost is an FP receptor antagonist that has been shown in clinical studies in Europe and Japan to be extremely useful in treating elevated intraocular pressure and glaucoma. The drug is well tolerated and appears to be at least equal in effectiveness and perhaps superior to other protanoids for routine use comparison to be superior to other treatments for the elevated IOP as the side effects and other related symptomology appear to be less, while maintaining a level of pressure control for prolonged periods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research